Global Blood Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference
03 janv. 2017 16h05 HE
|
Global Blood Therapeutics
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that it will present at the 35th Annual J.P. Morgan Healthcare...
Global Blood Therapeutics Added to NASDAQ Biotechnology Index
16 déc. 2016 08h30 HE
|
Global Blood Therapeutics
SOUTH SAN FRANCISCO, Calif., Dec. 16, 2016 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that it has been selected for addition to the NASDAQ Biotechnology...
Global Blood Therapeutics Announces Upcoming Investor Webcast to Review GBT440 Data Being Presented at ASH that Support Sickle Cell Disease Program
30 nov. 2016 16h05 HE
|
Global Blood Therapeutics
SOUTH SAN FRANCISCO, Calif., Nov. 30, 2016 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), today announced that it will host an investor webcast on Monday, December 5,...
Global Blood Therapeutics Announces Pivotal Study for GBT440 in Sickle Cell Disease with Primary Hemoglobin Endpoint
24 oct. 2016 16h05 HE
|
Global Blood Therapeutics
HOPE – A Phase 3 Clinical Trial to Initiate in December Company to Host Conference Call and Webcast Today at 1:30 p.m. PT/ 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., Oct. 24, 2016 (GLOBE NEWSWIRE)...
Global Blood Therapeutics Announces Appointment of Tricia Suvari as Chief Legal Officer
12 oct. 2016 08h00 HE
|
Global Blood Therapeutics
SOUTH SAN FRANCISCO, Calif., Oct. 12, 2016 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), a biopharmaceutical company developing novel therapeutics for the treatment...
Global Blood Therapeutics Joins Sickle Cell Disease (SCD) Coalition in Support of SCD Community with Goal to Improve Treatment and Care
06 sept. 2016 09h05 HE
|
Global Blood Therapeutics
SOUTH SAN FRANCISCO, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), a biopharmaceutical company developing novel therapeutics for the treatment...
Global Blood Therapeutics Announces Participation at Two Upcoming Investor Conferences in September
31 août 2016 16h05 HE
|
Global Blood Therapeutics
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2016 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), a biopharmaceutical company developing novel therapeutics for the treatment...
Global Blood Therapeutics Announces Participation at Three September Conferences
03 sept. 2015 07h35 HE
|
Global Blood Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT), a biopharmaceutical company developing novel therapeutics for the treatment of...